SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-036699
Filing Date
2024-04-26
Accepted
2024-04-26 17:00:35
Documents
67
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0203758-10q_actinium.htm   iXBRL 10-Q 799691
2 CERTIFICATION ea020375801ex31-1_actinium.htm EX-31.1 10274
3 CERTIFICATION ea020375801ex31-2_actinium.htm EX-31.2 10421
4 CERTIFICATION ea020375801ex32-1_actinium.htm EX-32.1 3402
5 CERTIFICATION ea020375801ex32-2_actinium.htm EX-32.2 3771
6 GRAPHIC image_001.jpg GRAPHIC 700598
7 GRAPHIC image_002.jpg GRAPHIC 16300
8 GRAPHIC image_003.jpg GRAPHIC 625923
9 GRAPHIC image_004.jpg GRAPHIC 533478
10 GRAPHIC image_005.jpg GRAPHIC 208664
11 GRAPHIC image_006.jpg GRAPHIC 700598
12 GRAPHIC image_007.jpg GRAPHIC 15025
13 GRAPHIC image_008.jpg GRAPHIC 20234
14 GRAPHIC image_009.jpg GRAPHIC 20725
15 GRAPHIC image_010.jpg GRAPHIC 211323
16 GRAPHIC image_011.jpg GRAPHIC 23127
17 GRAPHIC image_012.jpg GRAPHIC 14210
18 GRAPHIC image_013.jpg GRAPHIC 17470
19 GRAPHIC image_014.jpg GRAPHIC 21405
20 GRAPHIC image_015.jpg GRAPHIC 25497
  Complete submission text file 0001213900-24-036699.txt   11136328

Data Files

Seq Description Document Type Size
21 XBRL SCHEMA FILE atnm-20240331.xsd EX-101.SCH 33905
22 XBRL CALCULATION FILE atnm-20240331_cal.xml EX-101.CAL 27327
23 XBRL DEFINITION FILE atnm-20240331_def.xml EX-101.DEF 158091
24 XBRL LABEL FILE atnm-20240331_lab.xml EX-101.LAB 312697
25 XBRL PRESENTATION FILE atnm-20240331_pre.xml EX-101.PRE 153781
71 EXTRACTED XBRL INSTANCE DOCUMENT ea0203758-10q_actinium_htm.xml XML 258237
Mailing Address 100 PARK AVE., 23RD FLOOR NEW YORK NY 10017
Business Address 100 PARK AVE., 23RD FLOOR NEW YORK NY 10017 (646) 677-3870
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

IRS No.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36374 | Film No.: 24884949
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)